Clinical trial
Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic…
NCT00414531 · University of Oslo School of Pharmacy, Other · Completed
Key facts
| NCT number | NCT00414531 |
|---|---|
| Title | Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity |
| Official title | Investigations on Differences in Atorvastatin Metabolites Ratios as a Diagnostic Tool in Detecting Atorvastatin Induced Myotoxicity |
| Lead sponsor | University of Oslo School of Pharmacy, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Myotoxicity of Atorvastatin Treatment |
| Intervention type | Drug |
| Interventions | Atorvastatin |
| Enrollment | 53 |
| Start date | May 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Dec 21, 2006 |
| Last update posted | Dec 3, 2014 |
| Countries | Norway |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: